ALGN
Price
$187.74
Change
+$1.16 (+0.62%)
Updated
Jun 26 closing price
Capitalization
24.63B
33 days until earnings call
SRDX
Price
$29.09
Change
+$0.18 (+0.62%)
Updated
Jun 26 closing price
Capitalization
397.04M
33 days until earnings call
Interact to see
Advertisement

ALGN vs SRDX

Header iconALGN vs SRDX Comparison
Open Charts ALGN vs SRDXBanner chart's image
Align Technology
Price$187.74
Change+$1.16 (+0.62%)
Volume$509.09K
Capitalization24.63B
Surmodics
Price$29.09
Change+$0.18 (+0.62%)
Volume$43.78K
Capitalization397.04M
ALGN vs SRDX Comparison Chart in %
Loading...
ALGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALGN vs. SRDX commentary
Jun 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALGN is a StrongBuy and SRDX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 27, 2025
Stock price -- (ALGN: $187.74 vs. SRDX: $29.09)
Brand notoriety: ALGN: Notable vs. SRDX: Not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: ALGN: 54% vs. SRDX: 66%
Market capitalization -- ALGN: $24.63B vs. SRDX: $397.04M
ALGN [@Medical Specialties] is valued at $24.63B. SRDX’s [@Medical Specialties] market capitalization is $397.04M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.56B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALGN’s FA Score shows that 0 FA rating(s) are green whileSRDX’s FA Score has 0 green FA rating(s).

  • ALGN’s FA Score: 0 green, 5 red.
  • SRDX’s FA Score: 0 green, 5 red.
According to our system of comparison, ALGN is a better buy in the long-term than SRDX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALGN’s TA Score shows that 5 TA indicator(s) are bullish while SRDX’s TA Score has 6 bullish TA indicator(s).

  • ALGN’s TA Score: 5 bullish, 3 bearish.
  • SRDX’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, SRDX is a better buy in the short-term than ALGN.

Price Growth

ALGN (@Medical Specialties) experienced а +4.29% price change this week, while SRDX (@Medical Specialties) price change was -0.17% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.93%. For the same industry, the average monthly price growth was +0.51%, and the average quarterly price growth was +0.02%.

Reported Earning Dates

ALGN is expected to report earnings on Jul 30, 2025.

SRDX is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Medical Specialties (+0.93% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALGN($24.6B) has a higher market cap than SRDX($397M). SRDX has higher P/E ratio than ALGN: SRDX (71.51) vs ALGN (55.01). ALGN YTD gains are higher at: -9.961 vs. SRDX (-26.540). ALGN has higher annual earnings (EBITDA): 799M vs. SRDX (22.1M). ALGN has more cash in the bank: 973M vs. SRDX (35.2M). SRDX has less debt than ALGN: SRDX (33.9M) vs ALGN (127M). ALGN has higher revenues than SRDX: ALGN (3.86B) vs SRDX (138M).
ALGNSRDXALGN / SRDX
Capitalization24.6B397M6,196%
EBITDA799M22.1M3,615%
Gain YTD-9.961-26.54038%
P/E Ratio55.0171.5177%
Revenue3.86B138M2,799%
Total Cash973M35.2M2,764%
Total Debt127M33.9M375%
FUNDAMENTALS RATINGS
ALGN vs SRDX: Fundamental Ratings
ALGN
SRDX
OUTLOOK RATING
1..100
1311
VALUATION
overvalued / fair valued / undervalued
1..100
75
Overvalued
92
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
6593
PRICE GROWTH RATING
1..100
5263
P/E GROWTH RATING
1..100
7094
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ALGN's Valuation (75) in the Medical Specialties industry is in the same range as SRDX (92). This means that ALGN’s stock grew similarly to SRDX’s over the last 12 months.

ALGN's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as SRDX (100). This means that ALGN’s stock grew similarly to SRDX’s over the last 12 months.

ALGN's SMR Rating (65) in the Medical Specialties industry is in the same range as SRDX (93). This means that ALGN’s stock grew similarly to SRDX’s over the last 12 months.

ALGN's Price Growth Rating (52) in the Medical Specialties industry is in the same range as SRDX (63). This means that ALGN’s stock grew similarly to SRDX’s over the last 12 months.

ALGN's P/E Growth Rating (70) in the Medical Specialties industry is in the same range as SRDX (94). This means that ALGN’s stock grew similarly to SRDX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALGNSRDX
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
72%
Bullish Trend 1 day ago
62%
Momentum
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
72%
MACD
ODDS (%)
Bullish Trend 1 day ago
73%
Bearish Trend 1 day ago
64%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
74%
Bearish Trend 1 day ago
70%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
72%
Bullish Trend 1 day ago
64%
Advances
ODDS (%)
Bullish Trend 3 days ago
74%
Bullish Trend 12 days ago
67%
Declines
ODDS (%)
Bearish Trend 15 days ago
70%
Bearish Trend 19 days ago
68%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 5 days ago
79%
Aroon
ODDS (%)
Bullish Trend 5 days ago
81%
Bullish Trend 1 day ago
64%
View a ticker or compare two or three
Interact to see
Advertisement
ALGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BDN4.220.07
+1.69%
Brandywine Realty Trust
NCRA1.02N/A
N/A
Nocera
JBHT143.28-0.15
-0.10%
J.B. Hunt Transport Services
PRPL0.75N/A
-0.20%
Purple Innovation
PSNY1.10-0.01
-0.90%
Polestar Automotive Holding UK PLC

ALGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALGN has been loosely correlated with NVST. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if ALGN jumps, then NVST could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALGN
1D Price
Change %
ALGN100%
+0.62%
NVST - ALGN
64%
Loosely correlated
+1.55%
ICUI - ALGN
53%
Loosely correlated
-1.05%
ITGR - ALGN
53%
Loosely correlated
+0.89%
TWST - ALGN
51%
Loosely correlated
-0.14%
SAUHY - ALGN
49%
Loosely correlated
+1.25%
More

SRDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, SRDX has been loosely correlated with BDX. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if SRDX jumps, then BDX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SRDX
1D Price
Change %
SRDX100%
+0.62%
BDX - SRDX
39%
Loosely correlated
-0.54%
TFX - SRDX
37%
Loosely correlated
+0.36%
ALGN - SRDX
29%
Poorly correlated
+0.62%
UFPT - SRDX
28%
Poorly correlated
+0.21%
SYK - SRDX
27%
Poorly correlated
-0.47%
More